Bixiye
P81-17 New Drug-Related PA Criteria: Opioid Induced Constipation (OIC)
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2501 - 2510 ee natiijooyinka 3611
Bixiye
P35-18 Update: Change to TPA Business
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2018
Bixiye
P65-17 Clarification to Commercial Prior Authorization for Biologic Immunomodulators
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P39R1-18 Update: Blue Cross Contracts with eviCore to Expand Utilization Management for Post-Acute Care
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2018
Bixiye
P2-18 New Medical Drug PA Requirements for Voretigene Neparvovec (Luxturna)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 11, 2018
Bixiye
P11-18 Minnesota Health Care Programs (MHCP) Reimbursement Rate for Vaccine Administration
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P41-17 PCA Agencies Requirements
Taariikhda dhaqangalka Barnaamijka: Jul 17, 2017
Bixiye
P40-17 New Prior Authorization Requirements for Immunomodular Drugs
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2017
Bixiye
P20-18 2018 Renewal Changes Summary For Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P38-17 New Drug-Related Prior Authorization (PA) for Xolair
Taariikhda dhaqangalka Barnaamijka: Jul 05, 2017